Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study.

Autor: Susarla SK; Indian Immunologicals Limited, Hyderabad, Telangana, India. Electronic address: s.saikrishna@indimmune.com., Palkar S; Department of Paediatrics, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, India., Sv PS; Consultant Physician and Nephrologist, Apollo DRDO Hospital, Hyderabad, Telangana, India., Diwan A; Department of Medicine, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, India., Barsode S; Department of Medicine, Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, India., Satish M; Indian Immunologicals Limited, Hyderabad, Telangana, India., Rajashakar BC; Indian Immunologicals Limited, Hyderabad, Telangana, India., Sandhya G; Indian Immunologicals Limited, Hyderabad, Telangana, India., Lingala R; Indian Immunologicals Limited, Hyderabad, Telangana, India., Sahoo DP; Indian Immunologicals Limited, Hyderabad, Telangana, India.

Publikováno v: Vaccine [Vaccine] 2021 Apr 08; Vol. 39 (15), pp. 2088-2093. Date of Electronic Publication: 2021 Mar 17.